Tanvex BioPharma Statistics

Total Valuation

TPE:6541 has a market cap or net worth of TWD 11.95 billion. The enterprise value is 12.64 billion.

Market Cap	11.95B
Enterprise Value	12.64B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6541 has 238.49 million shares outstanding. The number of shares has increased by 33.39% in one year.

Current Share Class	238.49M
Shares Outstanding	238.49M
Shares Change (YoY)	+33.39%
Shares Change (QoQ)	+35.53%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	2.01%
Float	84.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	147.18
PB Ratio	2.15
P/TBV Ratio	6.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.84
EV / Sales	155.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.31

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.32.

Current Ratio	2.89
Quick Ratio	2.30
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.44
Interest Coverage	-26.03

Financial Efficiency

Return on equity (ROE) is -48.00% and return on invested capital (ROIC) is -17.04%.

Return on Equity (ROE)	-48.00%
Return on Assets (ROA)	-16.12%
Return on Invested Capital (ROIC)	-17.04%
Return on Capital Employed (ROCE)	-18.83%
Revenue Per Employee	410,015
Profits Per Employee	-7.22M
Employee Count	198
Asset Turnover	0.02
Inventory Turnover	0.51

Taxes

Income Tax	-2.70M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.20% in the last 52 weeks. The beta is -0.04, so TPE:6541's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	+27.20%
50-Day Moving Average	56.85
200-Day Moving Average	64.75
Relative Strength Index (RSI)	33.51
Average Volume (20 Days)	284,415

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6541 had revenue of TWD 81.18 million and -1.43 billion in losses. Loss per share was -8.06.

Revenue	81.18M
Gross Profit	-14.41M
Operating Income	-1.34B
Pretax Income	-1.43B
Net Income	-1.43B
EBITDA	-1.22B
EBIT	-1.34B
Loss Per Share	-8.06

Full Income Statement

Balance Sheet

The company has 1.08 billion in cash and 1.77 billion in debt, giving a net cash position of -689.29 million or -2.89 per share.

Cash & Cash Equivalents	1.08B
Total Debt	1.77B
Net Cash	-689.29M
Net Cash Per Share	-2.89
Equity (Book Value)	5.55B
Book Value Per Share	23.26
Working Capital	981.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.14 billion and capital expenditures -80.44 million, giving a free cash flow of -1.23 billion.

Operating Cash Flow	-1.14B
Capital Expenditures	-80.44M
Free Cash Flow	-1.23B
FCF Per Share	-5.14

Full Cash Flow Statement

Margins

Gross Margin	-17.74%
Operating Margin	-1,654.64%
Pretax Margin	-1,763.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.39%
Shareholder Yield	n/a
Earnings Yield	-11.96%
FCF Yield	-10.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.

Last Split Date	Mar 2, 2023
Split Type	Reverse
Split Ratio	0.3335779572

Scores

TPE:6541 has an Altman Z-Score of -0.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.01
Piotroski F-Score	3